TB and HIV Therapeutics: Pharmacology Research Priorities

por Dooley, Kelly E., Kim, Peter S., Williams, Sharon D., Hafner, Richard
Publicado 2012

Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug

por Svensson, Elin M., Murray, Stephen, Karlsson, Mats O., Dooley, Kelly E.
Publicado 2015

Evidence for Implementation: Management of TB in HIV and Pregnancy

por Jones, Amanda J., Mathad, Jyoti S., Dooley, Kelly E., Eke, Ahizechukwu C.
Publicado 2022

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

por Dooley, Kelly E., Hanna, Debra, Mave, Vidya, Eisenach, Kathleen, Savic, Radojka M.
Publicado 2019

Infectious Diseases Learning Unit: Understanding Advances in the Treatment of Latent Tuberculosis Infection Among People With Human Immunodeficiency Virus

por Mehtani, Nicky J, Puryear, Sarah, Pham, Paul, Dooley, Kelly E, Shah, Maunank
Publicado 2021

Pharmacokinetic Interactions for Drugs with a Long Half-Life—Evidence for the Need of Model-Based Analysis

por Svensson, Elin M., Acharya, Chayan, Clauson, Björn, Dooley, Kelly E., Karlsson, Mats O.
Publicado 2015

Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against Mycobacterium ulcerans Disease in Mice

por Almeida, Deepak, Converse, Paul J., Ahmad, Zahoor, Dooley, Kelly E., Nuermberger, Eric L., Grosset, Jacques H.
Publicado 2011

Tuberculous Meningitis in Children: Reducing the Burden of Death and Disability

por Huynh, Julie, Abo, Yara-Natalie, du Preez, Karen, Solomons, Regan, Dooley, Kelly E, Seddon, James A
Publicado 2021

Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco

por Dooley, Kelly E, Lahlou, Ouafae, Ghali, Iraqi, Knudsen, Janine, Elmessaoudi, My Driss, Cherkaoui, Imad, El Aouad, Rajae
Publicado 2011

Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso Cohort

por Salazar-Austin, Nicole, Cohn, Silvia, Lala, Sanjay, Waja, Ziyaad, Dooley, Kelly E, Hoffmann, Christopher J, Chaisson, Richard E, Martinson, Neil
Publicado 2019

Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: stu...

por Nabisere, Ruth, Musaazi, Joseph, Denti, Paolo, Aber, Florence, Lamorde, Mohammed, Dooley, Kelly E., Aarnoutse, Rob, Sloan, Derek J., Sekaggya-Wiltshire, Christine
Publicado 2020

INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabin...

por Naidoo, Anushka, Dooley, Kelly E, Naidoo, Kogieleum, Padayatchi, Nesri, Yende-Zuma, Nonhlanhla, Perumal, Rubeshan, Dorse, Gillian, Boodhram, Resha, Osuala, Emmanuella Chinonso
Publicado 2022

Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milk

por Mkhize, Buyisile, Kellermann, Tracy, Norman, Jennifer, Castel, Sandra, Joubert, Anton, van der Merwe, Marthinus, Dooley, Kelly E., Mathad, Jyoti S., Wiesner, Lubbe
Publicado 2022

A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis

por Wasmann, Roeland E., Masini, Tiziana, Viney, Kerri, Verkuijl, Sabine, Brands, Annemieke, Hesseling, Anneke C., McIlleron, Helen, Denti, Paolo, Dooley, Kelly E.
Publicado 2023

A treatment recommender clinical decision support system for personalized medicine: method development and proof-of-concept for drug resistant tuberculosis

por Verboven, Lennert, Calders, Toon, Callens, Steven, Black, John, Maartens, Gary, Dooley, Kelly E., Potgieter, Samantha, Warren, Robin M., Laukens, Kris, Van Rie, Annelies
Publicado 2022

A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis

por Verboven, Lennert, Callens, Steven, Black, John, Maartens, Gary, Dooley, Kelly E., Potgieter, Samantha, Cartuyvels, Ruben, Laukens, Kris, Warren, Robin M., Van Rie, Annelies
Publicado 2023

A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug–Drug Interactions With Antiretroviral and Antituberculosis Treatment

por Francis, Jose, Mngqibisa, Rosie, McIlleron, Helen, Kendall, Michelle A, Wu, Xingye, Dooley, Kelly E., Firnhaber, Cynthia, Godfrey, Catherine, Cohn, Susan E., Denti, Paolo
Publicado 2021

Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis

por Bigelow, Kristina M, Deitchman, Amelia N, Li, Si-Yang, Barnes-Boyle, Kala, Tyagi, Sandeep, Soni, Heena, Dooley, Kelly E, Savic, Rada M, Nuermberger, Eric L
Publicado 2020

Treatment Default amongst Patients with Tuberculosis in Urban Morocco: Predicting and Explaining Default and Post-Default Sputum Smear and Drug Susceptibility Results

por Cherkaoui, Imad, Sabouni, Radia, Ghali, Iraqi, Kizub, Darya, Billioux, Alexander C., Bennani, Kenza, Bourkadi, Jamal Eddine, Benmamoun, Abderrahmane, Lahlou, Ouafae, Aouad, Rajae El, Dooley, Kelly E.
Publicado 2014

Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review

por Jacobs, Tom G, Svensson, Elin M, Musiime, Victor, Rojo, Pablo, Dooley, Kelly E, McIlleron, Helen, Aarnoutse, Rob E, Burger, David M, Turkova, Anna, Colbers, Angela
Publicado 2020